These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7170068)

  • 1. [Natural killer activity of peripheral blood lymphocytes in patients with brain tumors].
    Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
    No Shinkei Geka; 1982 Dec; 10(12):1291-7. PubMed ID: 7170068
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circulating immune complexes in patients with intracranial neoplasms].
    Sztaba-Kania M; Piskorzyńska M; Borowska-Lehman J; Kopczyński S
    Nowotwory; 1982; 32(4):235-8. PubMed ID: 6310528
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpesvirus type 1 serum antibodies and brain tumors in humans.
    Hadfield MG; Murray BK; Thomson TA; Young HF
    Clin Neuropathol; 1984; 3(2):68-71. PubMed ID: 6325061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the cellular immune response of patients with cerebral glioma, benign intracranial tumour, and spontaneous subarachnoid haemorrhage measured in vitro by the leucocyte migration inhibition test.
    Bean JR; Darling JL; Hoyle NR; Arigbabu SO; Thomas DG
    Neurol Res; 1983; 5(1):61-75. PubMed ID: 6140656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating immune complexes associated with brain tumors. Correlation with histological differentiation and length of clinical history.
    Lauro GM; Grossi M; Di Lorenzo N
    Eur Neurol; 1983; 22(5):307-13. PubMed ID: 6628459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activity of the natural killer cells in the peripheral blood of patients with brain tumors].
    Lisianyĭ NI; Markova OV; Zhmareva EN
    Eksp Onkol; 1988; 10(3):57-9. PubMed ID: 3409835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tissue polypeptide antigen as a tumor marker of brain tumors].
    Sonoda H; Matsukado Y; Uemura S; Kaku M
    Neurol Med Chir (Tokyo); 1984 Sep; 24(9):655-62. PubMed ID: 6083488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of tumors specific humoral anitbody against brain tumors (author'stransl)].
    Shimizu T; Kito K; Kubota S; Kitamura K; Takakura K
    No Shinkei Geka; 1974; 2(11-12):747-56. PubMed ID: 4376831
    [No Abstract]   [Full Text] [Related]  

  • 10. [Humoral and cellular immunity in patients with left- and right-sided intracerebral tumors].
    Lisianyĭ NI; Markova OV; Prikhodchenko IA; Primushko LI
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):33-5. PubMed ID: 2787570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of glial fibrillary acid protein in brain tumors by the immunoperoxidase method].
    Bozóky B; Ormos J; Bodosi M
    Morphol Igazsagugyi Orv Sz; 1986 Jul; 26(3):173-9. PubMed ID: 3526137
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the immunological status of patients with cerebral neoplasms].
    Perria C; Di Benedetto G; Barabino A; Soldà AM; Indiveri F
    Boll Soc Ital Biol Sper; 1974 Nov; 50(22):1930-5. PubMed ID: 4376965
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lymphocyte subpopulations and their functional activity in patients with brain tumors].
    Rudenko VA; Lisianyĭ NI; Radzievskiĭ AA
    Vrach Delo; 1990 Sep; (9):91-4. PubMed ID: 2284786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
    Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
    Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viruses and brain tumors.
    Smith KO; Newman JT; Story JL; Wissinger JP
    Clin Neurosurg; 1974; 21():362-82. PubMed ID: 4371589
    [No Abstract]   [Full Text] [Related]  

  • 16. A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling.
    Bhattacharjee M; Bose I; Sarkar P; Banerjee C; Dutta S; Ghosh A; Mukherjee J; Acharya S; Goswami S; Mazumdar A; Chaudhuri S; Chaudhuri S
    Cancer Invest; 2006; 24(5):502-13. PubMed ID: 16939959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory infiltrates and natural killer cell presence in human brain tumors.
    Stevens A; Klöter I; Roggendorf W
    Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in patients with intracranial tumors.
    Suzuki Y; Tanaka R
    J Neurosurg; 1980 Sep; 53(3):355-60. PubMed ID: 7420150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human astrocytoma: serum-mediated immunologic response.
    Kornblith PL; Dohan FC; Wood WC; Whitman BO
    Cancer; 1974 Jun; 33(6):1512-9. PubMed ID: 4858205
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural killer cells in meningiomas.
    Vaquero J; Coca S; Pontón P; Oya S; Arias A
    Histol Histopathol; 1991 Jul; 6(3):369-72. PubMed ID: 1810535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.